With advances in gene technology surging forward, the government is developing plans for a biobank. The Department of Health is trying to find companies to take on this project, which will cost around NT$500 million (US$15.6 million). The biobank will be an important platform for gathering and analyzing gene information about the population, and will become a very important part of the infrastructure supporting the Taiwanese people's right to health and the development of the nation's biotech industry.
One condition for success is that the biobank must be trusted by the public. It will be necessary to offer the public a comprehensive explanation of the biobank's mechanisms, and let both laymen and academics monitor and participate in the operations of these mechanisms.
Guaranteeing people's privacy and basing the establishment of the biobank, as well as its practical direction, on decisions derived from public consensus mechanisms, are all aspects that will help lay a solid foundation for the development of the biotech field. The project should be based on democratic participation and trust.
First, because an understanding of gene sequences implies gaining access to the most intimate information about individuals and groups, the organization of the biobank will require very strict and diverse secrecy measures, as well as the creation of a secure certification system using strict secrecy principles to provide guarantees for individual privacy.
Second, to meet demands for individual privacy, the examination of gene data will use groups as the unit for analysis. This means that the results, positive or negative, will concern the group as a whole. As a result, the most difficult challenge will be to win the public's trust by building a mechanism for group consent.
In addition, realistic mechanisms should be put in place to deal with research results, such as new knowledge or profits, in order to reward the groups that provided the research material. These rewards should not only include freedom from harm such as defamation. More important is the possibility to share in the fruits of the research, in particular establishing reward mechanisms that provide substantial benefits, commensurate with risks. This will also be the major incentive to motivate group consent.
The reason for giving precedence to group consent over individual consent from members of the targeted communities is that individual consent will not be sufficient to establish gene data regarding the Taiwanese people.
The most important concern for the biobank will be how to define communities. They can be divided into communities representing all Taiwanese, communities from specific regions or race categories, or communities with a particular disease or gene. Defining different communities implies different applications for research results.
The purpose of a data bank representing the population as a whole is to further public health, but it is also easy to cause harm -- data leaks, for example, could expose the Taiwanese people to gene-based biotech terror attacks.
For people in a particular region, or members of the Minnan, Hakka or other communities, group consent should be obtained from the community concerned in order to guarantee its best interests. When dealing with particular diseases, patient groups and their relatives should be allowed to share in the fruits of the research results, and these groups should also be asked to provide group consent.
The biobank should therefore be focused on science and not on basic research, so when defining target population groups, researchers should build a consensus strong enough to convince the different groups instead of merely benefiting certain people in a few research institutions.
The founding of a biobank concerns the security and continued existence of specific communities and even the national population as a whole, and this also involves commercial interests. Something that is so important to the economy and our daily life requires the creation of a law for the protection and security of the gene information.
The implementation of legislation requires that priority be given to cooperation with the local business community with reference to the Statute for Upgrading Industries (促進產業升級條例) and other relevant regulations to create a healthy population while promoting biotech industry advances.
It would run counter to bioethics principles if a lack of domestic group consent results in a small number of research institutions and foreign manufacturers being given gene data in exchange for research results and commercial profit. That could produce very negative results, and it is necessary for the government to take full responsibility.
Wu Shuh-min is the president of the Foundation of Medical Professionals Alliance in Taiwan. Tsai Duujian is a professor in the Welfare Research Institute at National Yangming University and chairman of the Social Empowerment Association.
Translated by Perry Svensson
Recently, China launched another diplomatic offensive against Taiwan, improperly linking its “one China principle” with UN General Assembly Resolution 2758 to constrain Taiwan’s diplomatic space. After Taiwan’s presidential election on Jan. 13, China persuaded Nauru to sever diplomatic ties with Taiwan. Nauru cited Resolution 2758 in its declaration of the diplomatic break. Subsequently, during the WHO Executive Board meeting that month, Beijing rallied countries including Venezuela, Zimbabwe, Belarus, Egypt, Nicaragua, Sri Lanka, Laos, Russia, Syria and Pakistan to reiterate the “one China principle” in their statements, and assert that “Resolution 2758 has settled the status of Taiwan” to hinder Taiwan’s
Singaporean Prime Minister Lee Hsien Loong’s (李顯龍) decision to step down after 19 years and hand power to his deputy, Lawrence Wong (黃循財), on May 15 was expected — though, perhaps, not so soon. Most political analysts had been eyeing an end-of-year handover, to ensure more time for Wong to study and shadow the role, ahead of general elections that must be called by November next year. Wong — who is currently both deputy prime minister and minister of finance — would need a combination of fresh ideas, wisdom and experience as he writes the nation’s next chapter. The world that
The past few months have seen tremendous strides in India’s journey to develop a vibrant semiconductor and electronics ecosystem. The nation’s established prowess in information technology (IT) has earned it much-needed revenue and prestige across the globe. Now, through the convergence of engineering talent, supportive government policies, an expanding market and technologically adaptive entrepreneurship, India is striving to become part of global electronics and semiconductor supply chains. Indian Prime Minister Narendra Modi’s Vision of “Make in India” and “Design in India” has been the guiding force behind the government’s incentive schemes that span skilling, design, fabrication, assembly, testing and packaging, and
As former president Ma Ying-jeou (馬英九) wrapped up his visit to the People’s Republic of China, he received his share of attention. Certainly, the trip must be seen within the full context of Ma’s life, that is, his eight-year presidency, the Sunflower movement and his failed Economic Cooperation Framework Agreement, as well as his eight years as Taipei mayor with its posturing, accusations of money laundering, and ups and downs. Through all that, basic questions stand out: “What drives Ma? What is his end game?” Having observed and commented on Ma for decades, it is all ironically reminiscent of former US president Harry